Dec 11, 2019
MediSieve on the News
It’s been a very busy but exciting couple of months for us. You may have seen us in the national or industry news.
If you’ve missed it, we’ve included some highlights below for you to browse:
Hospimedica have showcased MediSieve and what we do: https://www.hospimedica.com/critical-care/articles/294780148/magnetic-blood-filtering-system-draws-out-disease.html
ldnconnected.co.uk published our latest news where we were announced as a winner of the ‘Breakthrough Medical or Healthcare Device Award’ in the Beanstalks competition 2019: https://ldnconnected.co.uk/medisieve-continues-growth-trajectory-with-latest-award/
Wonderful Engineering covered our profile piece that recently appeared in the Telegraph: https://wonderfulengineering.com/medisieve-is-a-new-technology-that-can-remove-diseases-from-the-blood-using-magnets/
It was also covered by Spring Wise: https://www.springwise.com/innovation/health-wellbeing/medisieve-treatment-technology-pulls-disease-from-blood-with-magnets?utm_source=rss&utm_medium=rss&utm_campaign=medical-device-may-filter-out-disease
We’ll keep you updated with all our latest news!
About Magnetic Blood Filtration
MediSieve's Magnetic Blood Filtration Platform is intended to enable the rapid and specific depletion of specific agents from the bloodstream of patients. The extracorporeal therapy uses therapeutic Magnetic Beads that are designed to bind specifically to the clinical target. The Beads are introduced into the extracorporeal circuit during the therapy, mixing with the patient’s blood and binding to the clinical targets. The Delivery Platform captures all the Magnetic Beads and bound targets, preventing their return to the patient.
MediSieve is a London-based BioTech start-up that has developed Magnetic Blood Filtration, a revolutionary platform therapy that enables the physical removal of specific substances from the bloodstream of patients. It can be used (1) as a direct treatment, (2) to increase the safety and efficacy of other therapies, or (3) to enable personalised medicine. The company is a spin-off from University College London and is developing its products at the White City Innovation District in West London. MediSieve is actively seeking investment and partnerships.
INVESTOR AND PARTNERSHIP CONTACT: